Post-translationally Modified Residues of Native Human Osteopontin Are Located in Clusters: Identification of 36 Phosphorylation and Five O-glycosylation Sites and Their Biological Implications

Overview

Journal Biochem J

Specialty Biochemistry

Date 2005 May 5

PMID 15869464

Citations 88

Authors

Brian Christensen

Mette S Nielsen

Kim F Haselmann

Torben E Petersen

Esben S Sorensen

Affiliations

Soon will be listed here.

Abstract

OPN (osteopontin) is an integrin-binding highly phosphorylated glycoprotein, recognized as a key molecule in a multitude of biological processes such as bone mineralization, cancer metastasis, cell-mediated immune response, inflammation and cell survival. A significant regulation of OPN function is mediated through PTM (post-translational modification). Using a combination of Edman degradation and MS analyses, we have characterized the complete phosphorylation and glycosylation pattern of native human OPN. A total of 36 phosphoresidues have been localized in the sequence of OPN. There are 29 phosphorylations (Ser8, Ser10, Ser11, Ser46, Ser47, Thr50, Ser60, Ser62, Ser65, Ser83, Ser86, Ser89, Ser92, Ser104, Ser110, Ser113, Thr169, Ser179, Ser208, Ser218, Ser238, Ser247, Ser254, Ser259, Ser264, Ser275, Ser287, Ser292 and Ser294) located in the target sequence of MGCK (mammary gland casein kinase) also known as the Golgi kinase (S/T-X-E/S(P)/D). Six phosphorylations (Ser101, Ser107, Ser175, Ser199, Ser212 and Ser251) are located in the target sequence of CKII (casein kinase II) [S-X-X-E/S(P)/D] and a single phosphorylation, Ser203, is not positioned in the motif of either MGCK or CKII. The 36 phosphoresidues represent the maximal degree of modification since variability at many sites was seen. Five threonine residues are O-glycosylated (Thr118, Thr122, Thr127, Thr131 and Thr136) and two potential sites for N-glycosylation (Asn63 and Asn90) are not occupied in human milk OPN. The phosphorylations are arranged in clusters of three to five phosphoresidues and the regions containing the glycosylations and the RGD (Arg-Gly-Asp) integrin-binding sequence are devoid of phosphorylations. Knowledge about the positions and nature of PTMs in OPN will allow a rational experimental design of functional studies aimed at understanding the structural and functional interdependences in diverse biological processes in which OPN is a key molecule.

Citing Articles

The Role of Osteopontin in Psoriasis-A Scoping Review.

Kimak A, Wozniacka A J Clin Med. 2024; 13(3).

PMID: 38337350 PMC: 10856165. DOI: 10.3390/jcm13030655.

Multi-Omics Profiling Identifies Microglial Annexin A2 as a Key Mediator of NF-κB Pro-inflammatory Signaling in Ischemic Reperfusion Injury.

Tian X, Yang W, Jiang W, Zhang Z, Liu J, Tu H Mol Cell Proteomics. 2024; 23(2):100723.

PMID: 38253182 PMC: 10879806. DOI: 10.1016/j.mcpro.2024.100723.

Osteopontin: A Novel Therapeutic Target for Respiratory Diseases.

Jia Q, Ouyang Y, Yang Y, Yao S, Chen X, Hu Z Lung. 2023; 202(1):25-39.

PMID: 38060060 DOI: 10.1007/s00408-023-00665-z.

Thrombin Cleavage of Osteopontin and the Host Anti-Tumor Immune Response.

Leung L, Myles T, Morser J Cancers (Basel). 2023; 15(13).

PMID: 37444590 PMC: 10340489. DOI: 10.3390/cancers15133480.

Milk Osteopontin and Human Health.

Sorensen E, Christensen B Nutrients. 2023; 15(11).

PMID: 37299387 PMC: 10255459. DOI: 10.3390/nu15112423.

References

Qin C, Cook R, Orkiszewski R, Butler W . Identification and characterization of the carboxyl-terminal region of rat dentin sialoprotein. J Biol Chem. 2000; 276(2):904-9. DOI: 10.1074/jbc.M006271200. View

Annan R, Carr S . Phosphopeptide analysis by matrix-assisted laser desorption time-of-flight mass spectrometry. Anal Chem. 1996; 68(19):3413-21. DOI: 10.1021/ac960221g. View

Hoyer J, Asplin J, Otvos L . Phosphorylated osteopontin peptides suppress crystallization by inhibiting the growth of calcium oxalate crystals. Kidney Int. 2001; 60(1):77-82. DOI: 10.1046/j.1523-1755.2001.00772.x. View

Razzouk S, Brunn J, Qin C, Tye C, Goldberg H, Butler W . Osteopontin posttranslational modifications, possibly phosphorylation, are required for in vitro bone resorption but not osteoclast adhesion. Bone. 2002; 30(1):40-7. DOI: 10.1016/s8756-3282(01)00637-8. View

Salih E, Wang J, Mah J, Fluckiger R . Natural variation in the extent of phosphorylation of bone phosphoproteins as a function of in vivo new bone formation induced by demineralized bone matrix in soft tissue and bony environments. Biochem J. 2002; 364(Pt 2):465-74. PMC: 1222592. DOI: 10.1042/BJ20011272. View

Boskey A, Spevak L, Paschalis E, Doty S, McKee M . Osteopontin deficiency increases mineral content and mineral crystallinity in mouse bone. Calcif Tissue Int. 2002; 71(2):145-54. DOI: 10.1007/s00223-001-1121-z. View

Weber G, Zawaideh S, Hikita S, Kumar V, Cantor H, Ashkar S . Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation. J Leukoc Biol. 2002; 72(4):752-61. View

Meggio F, Pinna L . One-thousand-and-one substrates of protein kinase CK2?. FASEB J. 2003; 17(3):349-68. DOI: 10.1096/fj.02-0473rev. View

Sorensen S, Justesen S, Johnsen A . Purification and characterization of osteopontin from human milk. Protein Expr Purif. 2003; 30(2):238-45. DOI: 10.1016/s1046-5928(03)00102-5. View

10.

Carlinfante G, Vassiliou D, Svensson O, Wendel M, Heinegard D, Andersson G . Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma. Clin Exp Metastasis. 2003; 20(5):437-44. DOI: 10.1023/a:1025419708343. View

11.

Andersson G, Ek-Rylander B, Hollberg K, Ljusberg-Sjolander J, Lang P, Norgard M . TRACP as an osteopontin phosphatase. J Bone Miner Res. 2003; 18(10):1912-5. DOI: 10.1359/jbmr.2003.18.10.1912. View

12.

Salih E, Fluckiger R . Complete topographical distribution of both the in vivo and in vitro phosphorylation sites of bone sialoprotein and their biological implications. J Biol Chem. 2004; 279(19):19808-15. DOI: 10.1074/jbc.M310299200. View

13.

Rittling S, Chambers A . Role of osteopontin in tumour progression. Br J Cancer. 2004; 90(10):1877-81. PMC: 2410284. DOI: 10.1038/sj.bjc.6601839. View

14.

Qin C, Baba O, Butler W . Post-translational modifications of sibling proteins and their roles in osteogenesis and dentinogenesis. Crit Rev Oral Biol Med. 2004; 15(3):126-36. DOI: 10.1177/154411130401500302. View

15.

Mercier J . Phosphorylation of caseins, present evidence for an amino acid triplet code posttranslationally recognized by specific kinases. Biochimie. 1981; 63(1):1-17. DOI: 10.1016/s0300-9084(81)80141-1. View

16.

Franzen A, Heinegard D . Isolation and characterization of two sialoproteins present only in bone calcified matrix. Biochem J. 1985; 232(3):715-24. PMC: 1152943. DOI: 10.1042/bj2320715. View

17.

Prince C, Oosawa T, Butler W, Tomana M, BHOWN A, Bhown M . Isolation, characterization, and biosynthesis of a phosphorylated glycoprotein from rat bone. J Biol Chem. 1987; 262(6):2900-7. View

18.

Barkholt V, Jensen A . Amino acid analysis: determination of cysteine plus half-cystine in proteins after hydrochloric acid hydrolysis with a disulfide compound as additive. Anal Biochem. 1989; 177(2):318-22. DOI: 10.1016/0003-2697(89)90059-6. View

19.

Senger D, Perruzzi C, Papadopoulos A, Tenen D . Purification of a human milk protein closely similar to tumor-secreted phosphoproteins and osteopontin. Biochim Biophys Acta. 1989; 996(1-2):43-8. DOI: 10.1016/0167-4838(89)90092-7. View

20.

Singh K, DeVouge M, Mukherjee B . Physiological properties and differential glycosylation of phosphorylated and nonphosphorylated forms of osteopontin secreted by normal rat kidney cells. J Biol Chem. 1990; 265(30):18696-701. View